What are the current options for managing patients with Cold Agglutinin Disease?
Currently, there are no FDA-approved treatments for patients with Cold Agglutinin Disease.1
CAD is currently managed by the following nonspecific approaches2:
- Cold avoidance*
- Crisis intervention; transfusions and/or plasmapheresis, which are often required to stabilize patients with severe anemia
Find out more about the burden of CAD here.